SEC Form 4 · accession 0001645627-17-000149
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Dec 21, 2017
Accepted (ET)
Dec 28, 2017 · 2:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2017 | P | 3,000 | $0.056 | A | 24,595,189 | D | |
| Common Stock | Dec 21, 2017 | P | 3,000 | $0.0549 | A | 24,598,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.06 | A | 24,601,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.06 | A | 24,604,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.06 | A | 24,607,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.06 | A | 24,610,189 | D | |
| Common Stock | Dec 26, 2017 | P | 2,476 | $0.06 | A | 24,612,665 | D | |
| Common Stock | Dec 26, 2017 | P | 524 | $0.06 | A | 24,613,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.06 | A | 24,616,189 | D | |
| Common Stock | Dec 26, 2017 | P | 2,000 | $0.065 | A | 24,618,189 | D | |
| Common Stock | Dec 26, 2017 | P | 3,000 | $0.072 | A | 24,621,189 | D | |
| Common Stock | Dec 26, 2017 | P | 1,750 | $0.076 | A | 24,622,939 | D | |
| Common Stock | Dec 26, 2017 | P | 1,250 | $0.0777 | A | 24,624,189 | D | |
| Common Stock | Dec 26, 2017 | P | 1,000 | $0.0777 | A | 24,625,189 | D | |
| Common Stock | Dec 26, 2017 | P | 2,000 | $0.0666 | A | 24,627,189 | D |
Table II — derivative securities
No Table II lines on this filing.